Navigation Links
Alexza's AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
Date:3/3/2008

of the Symphony Allegro Development Board. "These promising initial results are exciting. We look forward to working with our colleagues at Symphony Allegro to further analyze the data and determine the next steps in the clinical development of AZ-104."

AZ-104 Phase 2a Clinical Trial Design

The Phase 2a clinical trial was an in-clinic, multi-center, randomized, double blind, placebo-controlled study. The study was designed to evaluate the treatment of a single migraine attack in each of 160 migraine patients, with or without aura. In the trial design, three doses of AZ-104 (Staccato loxapine in 1.25, 2.5 and 5 mg doses) were evaluated against placebo (a Staccato device containing no drug). Patients reported to the clinic when they felt the onset of a migraine and were treated once their headache was considered to be of moderate or severe intensity. Patients stayed in the clinic for 4 hours post-dosing for various assessments and were monitored via patient diary for the remainder of the 24-hour evaluation period. The clinical trial enrolled 168 patients: 43 patients in the 1.25 mg dose group, 43 patients in the 2.5 mg dose group, 43 patients in the 5 mg dose group and 39 patients in the placebo dose group.

Patients rated their headache pain using the International Headache Society (IHS) 4-point rating scale. The primary efficacy endpoint was headache pain relief (headache pain rated as mild or none) at 2-hours post-dose. Secondary efficacy endpoints for the trial included various additional measurements of pain relief, as well as effects on nausea, vomiting, phonophobia and photophobia. All results were considered statistically significant at the p < 0.05 level and all analyses were made on an intent-to-treat basis. Side effects were recorded throughout the clinical trial study period.

Primary Efficacy Endpoint

AZ-104 met the primary efficacy endpoint of the clinical trial for two doses of the drug compared to placebo. Statistically
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
5. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
9. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
10. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
11. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... , March 26, 2015 Over-the-counter healthcare ... American consumer. However, a new survey of store ... from the common cold to diabetes, can offer ... research, conducted by the Private Label Manufacturers Association, ... healthcare products, including those essential for treatment of ...
(Date:3/26/2015)... -- A new survey of health care stakeholders ... will yield improvements in health care decision-making, but ... CER in the current environment. The National Pharmaceutical ... that they view CER as important, expect it ... decision-making in the next three to five years, ...
(Date:3/26/2015)... 26, 2015  Desert Valley Medical Center, named a ... is the first U.S. hospital to deploy the ... to help clinicians prevent hospital acquired pressure ulcers. ... , is a community hospital serving some higher ... Leaf Patient Monitor in the hospital,s emergency department enables ...
Breaking Medicine Technology:Consumers can keep over-the-counter medicine affordable by using store brands 2NPC Highlights Stakeholder Views on Comparative Effectiveness Research and the Environment for Health Care Decision-Making 2NPC Highlights Stakeholder Views on Comparative Effectiveness Research and the Environment for Health Care Decision-Making 3NPC Highlights Stakeholder Views on Comparative Effectiveness Research and the Environment for Health Care Decision-Making 4Desert Valley Medical Center First to Use Leaf Healthcare Patient Wearable Technology in its ED as Part of Hospital-wide Deployment 2Desert Valley Medical Center First to Use Leaf Healthcare Patient Wearable Technology in its ED as Part of Hospital-wide Deployment 3
... 2011 Sevocity, the leader in cloud-based Electronic ... achieved full certification through the Certification Commission for ... Certified® 2011 Ambulatory EHR.  Sevocity v11.1 also achieved ... level awarded by CCHIT.  The Certification Commission for ...
... -- 3SBio Inc. (NASDAQ: SSRX ) ... company focused on researching, developing, manufacturing and marketing ... Food and Drug Administration ("SFDA") has approved its ... treatment of anemia associated with chemotherapy in cancer ...
Cached Medicine Technology:Sevocity Division of Conceptual MindWorks Inc.'s Sevocity EHR Earns CCHIT 2011 Certification 23SBio Inc. Announces SFDA Approval of High-Dose EPIAO 23SBio Inc. Announces SFDA Approval of High-Dose EPIAO 33SBio Inc. Announces SFDA Approval of High-Dose EPIAO 4
(Date:3/27/2015)... OR (PRWEB) March 27, 2015 California’s ... winter blizzards in Boston and the United States Northeast, ... patterns. Earth warming global atmosphere is creating changes in ... PhD, historical climatologist and former NASA researcher, speaking on ... The result is not only a warmer and dryer ...
(Date:3/27/2015)... St. Paul, MN (PRWEB) March 27, 2015 ... first annual Minnesotans for Healthy Kids Coalition Lobby ... and the Statewide Health Improvement Program (SHIP). ... for the 2015 PE Bill SF343/HF498 which would ... benchmarks, require annual student assessments and other measures ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 Smile Brands ... providers of business support services to dental groups in ... an affiliated Castle Dental office in Hendersonville, ... Hendersonville, TN 37075, this new Castle Dental office provides ... receive the latest in comprehensive, quality dental care. Hendersonville ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 In light ... (case number 1:15-cv-10429, U.S. District Court, District of Massachusetts; ... the Eastern District of Pennsylvania), the San Diego personal ... Helbock, A.P.C. are announcing that they are available to ... of women who were prescribed Zofran while pregnant and ...
(Date:3/26/2015)... Dr. Rod J. Rohrich, who served ... and has trained over 6500 surgeons through these ... based medicine (EBM), that is, the optimization of decision ... "We often hear from rhinoplasty surgeons who ... certainly not trying to stifle these discussions, we do ...
Breaking Medicine News(10 mins):Health News:California Drought, Boston Blizzards Both Attributed to Global Climate Change Reports Climatologist to Fresh Water Advocate 2Health News:California Drought, Boston Blizzards Both Attributed to Global Climate Change Reports Climatologist to Fresh Water Advocate 3Health News:Everlast Climbing Advocates to Strengthen Physical Education in Minnesota Schools 2Health News:Castle Dental® Opens Its First Dental Office in Hendersonville, TN 2Health News:Castle Dental® Opens Its First Dental Office in Hendersonville, TN 3Health News:The Law Office of Melinda J. Helbock, A.P.C. Announces That It Is Now Accepting Case Reviews for Potential Zofran Birth Defect Lawsuits 2Health News:Dr. Rod Rohrich Explores Evidence Based Innovations and Safety at the 32nd Annual Dallas Rhinoplasty Symposium 2
... HealthDay Reporter , TUESDAY, Feb. 28 (HealthDay News) -- ... adults or children to its aftereffects, Canadian researchers report. ... is essential for reading and calculating, and those effects ... authors found. "Contrary to the belief by some ...
... to treating elderly cancer patients are evolving as more of ... more evident. To address these issues and others, national ... symposium at the Kimmel Cancer Center at Jefferson ... will present an overview of the latest advances in the ...
... SEATTLEAs soon as women quit hormone therapy, their rates ... stopping hormones can lead to tumor regression, according to ... Prevention . As part of the national ... data (with a median of 3.3 years per woman) ...
... of a tenfold boost to OARnet,s statewide network bandwidth, ... the state on Feb. 27 in a video teleconference ... enhance innovation. Together with researchers at The Ohio ... School of Medicine, Summa Western Reserve Hospital in Cuyahoga ...
... , TUESDAY, Feb. 28 (HealthDay News) -- A new ... to scientists at the U.S. Centers for Disease Control and Prevention. ... threat to humans, the CDC team cautioned that more research is ... of human flu. "This is the first time an influenza ...
... condoms less frequently during their first year of college, according ... Centers for Behavioral and Preventive Medicine. This was particularly true ... or come from lower socioeconomic backgrounds. The findings, published ... some of the first clues to how condom use changes ...
Cached Medicine News:Health News:Teens May Fare Worse After Concussion Than Children or Adults 2Health News:Teens May Fare Worse After Concussion Than Children or Adults 3Health News:A new battlefront: Symposium at Jefferson's Kimmel Cancer Center to tackle geriatric oncology 2Health News:A new battlefront: Symposium at Jefferson's Kimmel Cancer Center to tackle geriatric oncology 3Health News:Stopping hormones might help breast cancer to regress 2Health News:Kasich, doctors highlight the future of OARnet -- Ohio's Academic Research Network 2Health News:Kasich, doctors highlight the future of OARnet -- Ohio's Academic Research Network 3Health News:New Flu Discovered in Guatemalan Fruit Bats 2Health News:Women decrease condom use during freshman year of college, study finds 2
... Acid powder reagent once reconstituted offers the ... stability to help maximize laboratory productivity, minimize ... time. The proprietary technology of the Infinity ... shelf life and stability once reconstituted that ...
... Glucose Oxidase single liquid stable reagent ... of single liquid stability to help ... and provide quick result turnaround time. ... Glucose Oxidase reagent provides a long ...
... reagent is intended for the in ... serum. , Infinity Cholesterol powder reagent ... stability once reconstituted and convenience, but ... existing assays. The reagent is suitable ...
...
Medicine Products: